Macromolecular Crystallography Operations Core

Information

  • Research Project
  • 10031904
  • ApplicationId
    10031904
  • Core Project Number
    P30GM138396
  • Full Project Number
    1P30GM138396-01
  • Serial Number
    138396
  • FOA Number
    PAR-19-232
  • Sub Project Id
    7121
  • Project Start Date
    9/30/2020 - 4 years ago
  • Project End Date
    6/30/2025 - 7 months from now
  • Program Officer Name
  • Budget Start Date
    10/1/2020 - 4 years ago
  • Budget End Date
    9/30/2021 - 3 years ago
  • Fiscal Year
    2020
  • Support Year
    01
  • Suffix
  • Award Notice Date
    9/2/2020 - 4 years ago

Macromolecular Crystallography Operations Core

The GM/CA Macromolecular Crystallography (MX) Core has three main goals. We will provide a modern, powerful environment for sample screening, fine sample examination via rastering, and data collection in fixed-energy, SAD and MAD modes for single- or multi-crystal samples. GM/CA will create an intuitive, sophisticated, biologist-friendly user interface for beamline control and data processing and analysis for both on-site and remote users. We will implement beamline and software upgrades for optimal user operations in order to take advantage of the upgraded APS source (APS-U), which will be realized within this funding period. GM/CA Group Leader Dr. Robert Fischetti leads the MX Core, Dr. Craig Ogata (Operations Section Lead) leads the user program, and Dr. Sergey Stepanov (Controls Section Lead) leads the computing and networking effort. Beamlines 23ID-B and 23ID-D will be similarly configured with high-quality X-ray beams, instruments and software for diffraction experiments at user-selectable wavelengths with a beam of user-selectable size to enable macromolecular crystallography of challenging biomedical problems. GM/CA will provide powerful, user-friendly control software and a safe environment on the experimental floor for user experiments based on peer-reviewed applications for beam time. We will complete a project to upgrade aging beamline optics and to increase the flux of the 5-?m, 10-?m and 20-?m beams by focusing. With the upgraded optics, we will provide a beam down to 1-?m diameter for the APS-U source and will implement an improved endstation for accurate sample visualization and positioning, a scheme for rapid beam size changes between 1 ?m and 20 ?m, an upgraded user interface for rapid sample scanning and data collection, and integration of data analysis software to process multi-crystal datasets. We will test a variety of serial crystallography methods in order to provide this capability to users at the start of APS-U. We will continue a multi-tiered maintenance program to anticipate problems ahead of failures and provide full beamline capabilities to users for all scheduled beam time.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    P30
  • Administering IC
    GM
  • Application Type
    1
  • Direct Cost Amount
    1767101
  • Indirect Cost Amount
    0
  • Total Cost
  • Sub Project Total Cost
    1767101
  • ARRA Funded
    False
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
    NIGMS:1767101\
  • Funding Mechanism
    RESEARCH CENTERS
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    ARGONNE NATIONAL LABORATORY
  • Organization Department
  • Organization DUNS
    080307109
  • Organization City
    LEMONT
  • Organization State
    IL
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    604394803
  • Organization District
    UNITED STATES